Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1

Circulation Research

Volumn 89, Issue 12, 2001, Pages 1224-1230

  Froberg, M Kent ^a,c   Adams, Alice ^a   Seacotte, Nicole ^a   Parker Thornburg, Jan ^b   Kolattukudy, Pappachan ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus; Monocyte chemoattractant protein 1; Monocytes

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GREEN FLUORESCENT PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; INFLAMMATION; LUNG BLOOD VESSEL; MALE; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; TRANSGENIC MOUSE; UNITED STATES; VIRUS RECOMBINANT;

EID: 0035824909     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2401.100601     Document Type: Article

References (56)

1. Atherosclerosis: An inflammatory disease
2. The pathogenesis of atherosclerosis: An update
3. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
4. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
5. Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics
6. Phagocytosis of aggregated lipoprotein by macrophages: Low density lipoprotein receptor-dependent foam-cell formation
7. Low density lipoprotein undergoes oxidative modification in vivo
8. In vivo properties of monocyte chemoattractant protein-1
9. Chemokines. Leucocyte recruitment and activation cytokines
10. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo
11. Chemokines and atherosclerosis
12. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1
13. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation
14. High level of monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens
15. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle
16. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats
17. Monocyte chemoattractant protein-1 in human atheromatous plaques
18. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
19. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein
20. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptordeficient mice
21. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
22. Decreased lesion formation in CCR2-1-mice reveals a role for chemokines in the initiation of atherosclerosis
23. Virus induced atherosclerosis
24. Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens
25. Virus-induced atherosclerosis: Herpesvirus infection alters aortic cholesterol metabolism and accumulation
26. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients
27. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
28. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
29. The role of infection in restenosis and atherosclerosis: Focus on cytomegalovirus
30. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
31. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
32. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection
33. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice
34. Cytomegalovirus infection increases development of atherosclerosis in apo-E knockout mice
35. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: Contribution of CMV-enhanced endothelial ICAM-1
36. Alterations in the expression of ELAM-1, ICAM-1, and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus
37. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression
38. Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus
39. Detection of activated T lymphocytes in the human atherosclerotic plaque
40. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions
41. The effects of cytomegalovirus infection on polar lipids and neutral lipids in cultured human cells
42. Cellular localization of latent murine cytomegalovirus
43. Cytomegalovirus cell tropism, replication, and gene transfer in brain
44. Use of the avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
45. Monocytes harboring cytomegalovirus: Interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein
46. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: An in vitro model
47. Cytomegalovirus antigen within human arterial smooth muscle cells
48. Interaction of human cytomegalovirus with p53: Possible role in coronary restenosis
49. Lungs are a major organ site of cytomegalovirus latency and recurrence
50. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration
51. Monocyte chemoattractant protein-1 binding by cytomegalovirus-infected endothelial cells
52. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells
53. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus
54. Moderate alcohol feeding attenuates postinjury vascular cell proliferation in rabbit angioplasty model
55. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after baloon injury in cholesterol-fed rabbits
56. Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression